Published October 12, 2020 | Version v1
Dataset Open

Development, evaluation, and validation of machine learning models for COVID-19 detection based on routine blood tests

  • 1. DISCo, Università degli Studi di Milano-Bicocca, Viale Sarca 336, Milano, 20126, Italy
  • 2. IRCCS Istituto Ortopedico Galeazzi, Orthopaedic Biotechnology Lab, Via Riccardo Galeazzi, 4, 20161, Milano, Italy
  • 3. SCVSA Department, University of Parma, Parco Area delle Science 11/a, 43124, Parma, Italy
  • 4. Vita-Salute San Raffaele University; Unit of Genomics for Human Disease Diagnosis, Division of Genetics and Cell Biology., Via Olgettina 58, 20132, Milan, Italy
  • 5. Laboratory Medicine, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy

Description

The .xlsx dataset includes all patients used for training, internal-external and external validation: these can be distinguished by looking at the ID (first column) in the dataset: those in format Axxxx-<Date> are the data used for the training, those in the format 20xx are the data used for the internal-external validation, while the remaining data were used for external validation.

As regards the features: for the Target feature the value 1 stands for "Positive to COVID-19" while the value 0 stands for "Negative to COVID-19"; while for the Sex feature the value 1 stands for "Male" while the value 0 stands for "Female".

The full article is available at: https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-1294/article-10.1515-cclm-2020-1294.xml.

A pre-print version of the article is also available on MedrXiv: https://www.medrxiv.org/content/10.1101/2020.10.02.20205070v1

ABSTRACT

Background The rRT-PCR test, the current gold standard for the detection of coronavirus disease (COVID-19), presents with known shortcomings, such as long turnaround time, potential shortage of reagents, false-negative rates around 15–20%, and expensive equipment. The hematochemical values of routine blood exams could represent a faster and less expensive alternative. 

Methods Three different training data set of hematochemical values from 1,624 patients (52% COVID-19 positive), admitted at San Raphael Hospital (OSR) from February to May 2020, were used for developing machine learning (ML) models: the complete OSR dataset (72 features: complete blood count (CBC), biochemical, coagulation, hemogasanalysis and CO-Oxymetry values, age, sex and specific symptoms at triage) and two sub datasets (COVID-specific and CBC dataset, 32 and 21 features respectively). 58 cases (50% COVID-19 positive) from another hospital, and 54 negative patients collected in 2018 at OSR, were used for internal-external and external validation.

Results We developed five ML models: for the complete OSR dataset, the area under the receiver operating characteristic curve (AUC) for the algorithms ranged from 0.83 to 0.90; for the COVID-specific dataset from 0.83 15 to 0.87; and for the CBC dataset from 0.74 to 0.86. The validations also achieved good results: respectively, AUC 16 from 0.75 to 0.78; and specificity from 0.92 to 0.96. 

Conclusions ML can be applied to blood tests as both an adjunct and alternative method to rRT-PCR for the fast and cost-effective identification of COVID-19-positive patients. This is especially useful in developing countries, or in countries facing an increase in contagions.

Files

Files (303.7 kB)

Name Size Download all
md5:a0a7a04a687c019a17330c6b9f97fc66
303.7 kB Download